An AI system tested thousands of drug combinations for IPF (lung scarring disease) and found a 7-drug mix that could keep lung capacity near normal — exciting news, though real human trials are still needed.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
This week, our database grew to over 7,400 research papers and nearly 1,850 clinical trials (studies testing treatments in real people) focused on IPF. Most active research is coming from Russian- and Chinese-language science communities, which means important discoveries may be happening worldwide that English speakers don't always hear about first.
The AI tested drug combinations and found a 7-drug mix that kept lung capacity (FVC — a measure of how much air your lungs can hold) at 98.3%. That basically means lungs performing almost like healthy lungs. The drugs target different parts of the scarring process at once, like fixing a leaky roof from multiple angles. This is still computer modeling, not a human trial yet — but it points researchers toward very specific combinations worth testing next.
One question to ask your lung doctor at your next visit: 'Are there any combination drug trials open right now that I might qualify for?'